Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • DRUGS AND BIOLOGICS—U.S.: Three states file Supreme Court challenge against Democratic states’ shield laws
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—OTHER AGENCY DOCUMENTS: Market forces shape Medicare spending beyond payment rules
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—E.D. Tenn.: McKesson brought about the proper removal of an opioid diversion case to federal court
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—GAO REPORTS: GAO recommends DEA and FDA update policies on drug scheduling processes
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ENFORCEMENT ACTIONS—NOTICES: DEA revokes registration over federal health program exclusion
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • GENERAL HEALTH CARE NEWS—M.D. La.: Claim against MSA administrator for underpayment of medical bills dismissed
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HEALTH CARE EMPLOYMENT ISSUES—7th Cir.: Hospital pharmacist’s vaccine-bias suit fails over accommodation hardship
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ORGAN PROCUREMENT AND TRANSPLANTATION—NOTICES: HRSA finalizes donor-focused organ donation reimbursement rules
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • SAFETY AND EFFECTIVENESS—NOTICES: FDA withdraws MYSOLINE suspension approval after manufacturer waives hearing rights
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, ENFORCEMENT ACTIONS—NOTICES: DEA revokes registration over federal health program exclusion, (Oct 1, 2026)

    By WK Editorial Staff

    DEA revoked a New Jersey physician’s registration after finding that a long-term exclusion from federal health care programs triggered statutory grounds for loss of controlled-substance prescribing authority.

    A New Jersey physician’s DEA ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use